Chad Winters - 04 Dec 2023 Form 4/A Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
VP, Chief Accounting Officer
Signature
/s/ Luis Cantarero
Issuer symbol
WST
Transactions as of
04 Dec 2023
Net transactions value
-$229,069
Form type
4/A
Filing time
21 Dec 2023, 12:54:47 UTC
Date Of Original Report
05 Dec 2023
Previous filing
05 Dec 2023
Next filing
22 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Options Exercise $65,404 +456 +31% $143.43 1,942 04 Dec 2023 Direct F1
transaction WST Common Stock Sale $353,541 -1,013 -44% $349.00 1,270 04 Dec 2023 Direct F1
transaction WST Common Stock Options Exercise $59,068 +341 +18% $173.22 2,283 04 Dec 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Stock Options (Right to Buy) Options Exercise $0 -456 -100% $0.000000* 0 04 Dec 2023 Stock Options (Right to Buy) 456 $143.43 Direct F1
transaction WST Stock Options (Right to Buy) Options Exercise $0 -341 -18% $0.000000 1,571 04 Dec 2023 Stock Options (Right to Buy) 341 $173.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a revision to accurately reflect option exercises and sales that Chad Winters requested on December 1, 2023 that were completed on December 4, 2023 due to a record-keeping system outage.